When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program

Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies

(2015) M.C. Hochberg   OSTEOARTHRITIS AND CARTILAGE

Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial

(2013) Andra Rodica Balanescu et al.   ANNALS OF THE RHEUMATIC DISEASES

Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

(2013) Mark T. Brown et al.   ARTHRITIS AND RHEUMATISM

Treatment of Femoral Head Osteonecrosis in the United States: 16-year Analysis of the Nationwide Inpatient Sample

(2013) Aaron J. Johnson et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee

(2013) Egilius L.H. Spierings et al.   PAIN

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

(2013) Alan J. Kivitz et al.   PAIN

Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management

(2012) Laura McKelvey et al.   JOURNAL OF NEUROCHEMISTRY

Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

(2012) Mark T. Brown et al.   JOURNAL OF PAIN

The effect of nonsteroidal anti-inflammatory drugs on tissue healing

(2012) Michael R. Chen et al.   KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY

Control of Arthritis Pain with Anti–Nerve-Growth Factor: Risk and Benefit

(2012) Matthias F. Seidel et al.   Current Rheumatology Reports

Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain

(2011) Patrick W. Mantyh et al.   ANESTHESIOLOGY

Rapidly Progressive Osteoarthritis: Biomechanical Considerations

(2011) Eric A. Walker et al.   Magnetic Resonance Imaging Clinics of North America

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study

(2011) H. Nagashima et al.   OSTEOARTHRITIS AND CARTILAGE

Efficacy and safety of tanezumab in the treatment of chronic low back pain

(2011) Nathaniel Katz et al.   PAIN

A Study to Investigate Tanezumab in Patients with Interstitial Cystitis/Painful Bladder Syndrome

(2011) Alexis E. Te   Current Urology Reports

Disease-specific clinical problems associated with the subchondral bone

(2010) Dietrich Pape et al.   KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY

Osteonecrosis of the Knee: A Review of Three Disorders

(2009) Michael G. Zywiel et al.   ORTHOPEDIC CLINICS OF NORTH AMERICA

Rapid destruction of the hip joint in osteoarthritis

(2008) T Yamamoto et al.   ANNALS OF THE RHEUMATIC DISEASES

The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors

(2008) Stephen Skaper   CNS & Neurological Disorders-Drug Targets

Rapidly destructive osteoarthritis of the hip joint: a case series

(2008) Sameer Batra et al.   Journal of Orthopaedic Surgery and Research